Your browser doesn't support javascript.
loading
Treatment interruption patterns and adverse events among patients on bedaquiline containing regimen under programmatic conditions in India.
Natarajan, Sekar; Singla, Rupak; Singla, Neeta; Gupta, Amitesh; Caminero, Jose A; Chakraborty, Amartya; Kumar, Vikas.
Affiliation
  • Natarajan S; Department of Tuberculosis and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India.
  • Singla R; Department of Tuberculosis and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India. Electronic address: drrupaksingla@yahoo.com.
  • Singla N; Department of Epidemiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India.
  • Gupta A; Department of Tuberculosis and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India.
  • Caminero JA; University Hospital of Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Spain.
  • Chakraborty A; Department of Tuberculosis and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India.
  • Kumar V; Department of Tuberculosis and Chest Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India.
Pulmonology ; 28(3): 203-209, 2022.
Article in En | MEDLINE | ID: mdl-33121945

Full text: 1 Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Country/Region as subject: Asia Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Country/Region as subject: Asia Language: En Year: 2022 Type: Article